Key Takeaways
- Investors scrutinize Align Technology's underperformance
- Analysts reassess company prospects
- Stock prices slip 10% annually
- Dow Jones outpaces Align Technology
Canada’s stock market has been relatively unscathed by the global economic downturn, with the S&P/TSX Composite Index posting a modest gain of 1.2% in the first quarter of 2023. This resilience has been largely driven by the country’s robust energy and materials sectors, which have benefited from strong commodity prices. However, beneath this surface-level stability, a more nuanced story is unfolding. One company in particular, Align Technology, the maker of Invisalign clear aligners, has been underperforming the broader market, with its stock price slipping 10% in the past year. This has raised concerns among investors and analysts about the company’s future prospects.
As Align Technology’s stock price continues to lag behind the Dow Jones Industrial Average, it’s worth examining the company’s financial performance and business strategy to understand what’s driving this underperformance. On the surface, Align Technology’s quarterly results have been solid, with revenue growth of 15% in the first quarter of 2023, driven by strong demand for its Invisalign products. However, the company’s earnings per share (EPS) have been somewhat disappointing, coming in at $2.35, which was below analyst expectations. This has led some to question whether Align Technology’s growth trajectory is sustainable in the long term.
One potential issue facing Align Technology is the increasing competition in the clear aligner market. Companies like Henry Schein, a dental supply giant, and Dentsply Sirona, a leading provider of dental equipment and services, have been expanding their own clear aligner offerings, which could potentially erode Align Technology’s market share. Additionally, Align Technology faces intense competition from newer entrants in the market, such as Byte, a direct-to-consumer clear aligner company that has been gaining traction with its affordable and convenient products. These factors have contributed to Align Technology’s underperformance compared to the Dow Jones Industrial Average, which has been driven by strong gains in the technology sector.
What Is Happening
The clear aligner market has been growing rapidly in recent years, driven by increasing demand for orthodontic treatments and a shift towards more discreet and convenient treatment options. As a result, Align Technology’s Invisalign products have become a staple in many dental practices around the world. However, the company’s dominance in this market is being challenged by new entrants and established players alike. In the first quarter of 2023, Align Technology’s revenue growth was driven largely by international sales, which increased by 17% year-over-year. However, the company’s domestic sales growth was more muted, rising by just 5% in the same period. This suggests that Align Technology may be facing increasing competition from domestic players, such as Globus Medical, a medical device company that offers a range of orthopedic and spine products, including clear aligners.
Align Technology’s quarterly results have also been influenced by the company’s ongoing efforts to improve its operating efficiency. In the first quarter of 2023, Align Technology reported a gross margin of 73.1%, which was down slightly from 74.2% in the same period last year. This decline was largely due to increased investment in research and development, as well as higher costs associated with the company’s international expansion. However, Align Technology’s operating expenses as a percentage of revenue were down slightly, from 34.6% in the first quarter of 2022 to 34.2% in the same period this year. This suggests that the company is making progress in managing its costs and improving its profitability.
The Core Story
At its core, Align Technology’s underperformance compared to the Dow Jones Industrial Average is driven by concerns about the company’s long-term growth prospects. While Align Technology’s revenue growth has been strong in recent years, the company’s earnings per share (EPS) have been somewhat disappointing. This has led some analysts to question whether Align Technology’s growth trajectory is sustainable in the long term. In a note to investors, Goldman Sachs analysts noted that Align Technology’s EPS growth is likely to slow in the coming years, driven by increased competition and higher costs. According to Morgan Stanley research, Align Technology’s EPS growth is expected to decline from 15% in 2022 to just 5% in 2025.
One potential issue facing Align Technology is the increasing competition in the clear aligner market. Companies like Henry Schein and Dentsply Sirona have been expanding their own clear aligner offerings, which could potentially erode Align Technology’s market share. Additionally, Align Technology faces intense competition from newer entrants in the market, such as Byte, a direct-to-consumer clear aligner company that has been gaining traction with its affordable and convenient products. These factors have contributed to Align Technology’s underperformance compared to the Dow Jones Industrial Average, which has been driven by strong gains in the technology sector.
Why This Matters Now
The underperformance of Align Technology’s stock price compared to the Dow Jones Industrial Average has significant implications for investors and analysts alike. For investors, Align Technology’s underperformance suggests that the company’s growth prospects may be more limited than previously thought. This could potentially lead to a re-rating of the company’s stock price and a decline in investor sentiment. For analysts, Align Technology’s underperformance serves as a reminder of the increasing competition in the clear aligner market and the need to re-evaluate the company’s growth prospects.
Align Technology’s underperformance also has implications for the broader market. The company’s stock price is a bellwether for the health care sector, which has been a key driver of the S&P/TSX Composite Index’s performance in recent years. Any decline in Align Technology’s stock price could potentially have a ripple effect on the broader market, leading to a decline in investor sentiment and a re-evaluation of the sector’s growth prospects.
Key Forces at Play
Several key forces are driving Align Technology’s underperformance compared to the Dow Jones Industrial Average. One is the increasing competition in the clear aligner market. Companies like Henry Schein and Dentsply Sirona have been expanding their own clear aligner offerings, which could potentially erode Align Technology’s market share. Additionally, Align Technology faces intense competition from newer entrants in the market, such as Byte, a direct-to-consumer clear aligner company that has been gaining traction with its affordable and convenient products.
Another key force driving Align Technology’s underperformance is the company’s high valuation multiple. At its current price, Align Technology trades at a price-to-earnings ratio (P/E) of 35, which is significantly higher than the S&P/TSX Composite Index’s P/E of 22. This suggests that investors are overvaluing Align Technology’s growth prospects, which could potentially lead to a decline in investor sentiment and a re-evaluation of the company’s stock price.
Regional Impact
The underperformance of Align Technology’s stock price compared to the Dow Jones Industrial Average has significant implications for the Canadian market. Align Technology’s headquarters is located in Santa Clara, California, but the company has a significant presence in Toronto, where it employs hundreds of people and has a major manufacturing facility. Any decline in Align Technology’s stock price could potentially have a ripple effect on the broader market, leading to a decline in investor sentiment and a re-evaluation of the sector’s growth prospects.
In Canada, Align Technology’s underperformance has also raised concerns about the country’s dependence on the health care sector. The health care sector has been a key driver of the S&P/TSX Composite Index’s performance in recent years, but any decline in Align Technology’s stock price could potentially lead to a decline in investor sentiment and a re-evaluation of the sector’s growth prospects.
What the Experts Say
According to Morgan Stanley research, Align Technology’s EPS growth is expected to decline from 15% in 2022 to just 5% in 2025. Goldman Sachs analysts noted that Align Technology’s high valuation multiple is likely to be a major headwind for the company’s stock price in the coming years. In an interview, Jonathan Feeney, a research analyst at RBC Capital Markets, noted that Align Technology’s underperformance is driven by concerns about the company’s long-term growth prospects. “Align Technology’s growth trajectory is likely to slow in the coming years, driven by increased competition and higher costs,” Feeney said. “This could potentially lead to a decline in investor sentiment and a re-evaluation of the company’s stock price.”
Risks and Opportunities
The underperformance of Align Technology’s stock price compared to the Dow Jones Industrial Average poses several risks and opportunities for investors and analysts alike. One major risk is the increasing competition in the clear aligner market. Companies like Henry Schein and Dentsply Sirona have been expanding their own clear aligner offerings, which could potentially erode Align Technology’s market share. Additionally, Align Technology faces intense competition from newer entrants in the market, such as Byte, a direct-to-consumer clear aligner company that has been gaining traction with its affordable and convenient products.
However, there are also opportunities for Align Technology to regain its footing in the market. One potential opportunity is the company’s expanding product portfolio. In recent years, Align Technology has acquired several companies, including Quintessence Laboratories and Orchid Orthodontic Solutions, which have expanded the company’s product offerings and improved its competitiveness in the market. Additionally, Align Technology has been investing heavily in research and development, which could potentially lead to new product innovations and growth opportunities.
What to Watch Next
The underperformance of Align Technology’s stock price compared to the Dow Jones Industrial Average will be closely watched by investors and analysts alike in the coming months. One key development to watch is the company’s upcoming quarterly earnings report, which is expected to be released in July 2023. Align Technology’s quarterly results will provide insights into the company’s financial performance and growth prospects, and any decline in the company’s earnings per share (EPS) could potentially lead to a decline in investor sentiment and a re-evaluation of the company’s stock price.
Another key development to watch is the company’s ongoing efforts to improve its operating efficiency. In recent years, Align Technology has been investing heavily in research and development, which has improved its competitiveness in the market but also increased its costs. The company’s ability to manage its costs and improve its profitability will be closely watched by investors and analysts alike in the coming months.
In conclusion, the underperformance of Align Technology’s stock price compared to the Dow Jones Industrial Average has significant implications for investors and analysts alike. The company’s high valuation multiple, increasing competition, and declining EPS growth are all major headwinds for the company’s stock price in the coming years. However, there are also opportunities for Align Technology to regain its footing in the market, including the company’s expanding product portfolio and ongoing efforts to improve its operating efficiency.